3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Brain Neoplasms
11
Prostatic Neoplasms
7
Breast Neoplasms
7
Neoplasms
6
Pancreatic Neoplasms
4
Uterine Cervical Neoplasms
2
Retinoblastoma
2
Lung Neoplasms
2
Liver Neoplasms
2
Glioma
2
Glioblastoma
2
Esophageal Squamous Cell Carcinoma
2
Disease
2
Central Nervous System Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Urinary Bladder Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Thyroid Nodule
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Tumor of Cervical Spine
1
Soft Tissue Neoplasms
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Prostate Cancer, Hereditary, 7
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Magnetic Resonance Imaging
1
Indocyanine Green
1
High-Energy Shock Waves
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Soft Tissue Neoplasms
×
Magnetic Resonance Imaging
×
Clear all
NCT04394052
2020-07-21
TUMOSTEO II
Central Hospital, Nancy, France
Recruiting
740 enrolled